Sign In

Clp. Osama Nabulsi

Global Head BD&L, M&A and Divestment

OSAMA NABULSI, CLP. is a senior executive at Novartis, currently serving as the Global Head of BD&L, M&A, and Divestment for the Sandoz Division. He has extensive experience in leadership roles within the pharmaceutical industry, particularly in business development, mergers and acquisitions, and divestment strategies.

Nabulsi holds a CLP (Certified Licensing Professional) certification, indicating his expertise in licensing and technology transfer.1 He received his education from Pepperdine University's George L. Graziadio School of Business and Management.1

In his professional career, Nabulsi has been actively involved in various aspects of the pharmaceutical business. He has shared insights on topics such as the use of artificial intelligence in enhancing data analysis within the industry.3 His LinkedIn profile suggests that he is based in Basel, Switzerland, which aligns with Novartis' global headquarters location.2

Nabulsi appears to be an engaged professional on social media platforms like LinkedIn, where he shares industry-related content and insights. For instance, he recently posted about the advantages of using AI in business processes and the transformative impact of artificial intelligence on the industry.3

Related Questions

What are some of the key projects Osama Nabulsi has led at Novartis?
How has Osama Nabulsi's career evolved over the years?
What are the main responsibilities of the Global Head of BD&L, M&A, and Divestment at Novartis?
What are some of the recent trends in M&A and divestment that Osama Nabulsi has commented on?
How does Osama Nabulsi incorporate AI into his business strategies?
Clp. Osama Nabulsi
Clp. Osama Nabulsi, photo 1
Clp. Osama Nabulsi, photo 2
Add to my network

Location

Basel, Basel, Switzerland